Excel Industries Ltd
Excel Industries is engaged in manufacturing and selling of Chemicals, Pharma intermediates and Environmental products. [1]
- Market Cap ₹ 1,402 Cr.
- Current Price ₹ 1,116
- High / Low ₹ 1,760 / 798
- Stock P/E 16.8
- Book Value ₹ 936
- Dividend Yield 0.49 %
- ROCE 9.99 %
- ROE 7.41 %
- Face Value ₹ 5.00
Pros
- Company is almost debt free.
- Stock is trading at 1.19 times its book value
- Company has been maintaining a healthy dividend payout of 28.2%
Cons
- The company has delivered a poor sales growth of 6.84% over past five years.
- Company has a low return on equity of 5.56% over last 3 years.
- Working capital days have increased from 84.9 days to 137 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
416 | 482 | 435 | 446 | 582 | 825 | 702 | 749 | 1,178 | 1,090 | 826 | 978 | |
376 | 409 | 372 | 402 | 457 | 574 | 571 | 627 | 946 | 960 | 800 | 857 | |
Operating Profit | 40 | 72 | 62 | 44 | 125 | 251 | 131 | 122 | 232 | 129 | 26 | 121 |
OPM % | 10% | 15% | 14% | 10% | 21% | 30% | 19% | 16% | 20% | 12% | 3% | 12% |
4 | 7 | 2 | 9 | 3 | 4 | 8 | 8 | 14 | 9 | 29 | 26 | |
Interest | 12 | 14 | 13 | 11 | 7 | 3 | 4 | 3 | 3 | 3 | 3 | 2 |
Depreciation | 11 | 15 | 15 | 14 | 15 | 18 | 23 | 27 | 31 | 31 | 31 | 34 |
Profit before tax | 21 | 50 | 37 | 28 | 106 | 233 | 112 | 100 | 212 | 104 | 20 | 111 |
Tax % | 15% | 19% | 31% | 25% | 31% | 35% | 17% | 30% | 24% | 25% | 25% | 25% |
17 | 41 | 25 | 21 | 73 | 152 | 93 | 70 | 160 | 78 | 15 | 84 | |
EPS in Rs | 16.03 | 34.07 | 19.53 | 16.55 | 57.71 | 120.96 | 74.36 | 55.84 | 127.41 | 62.41 | 12.02 | 66.42 |
Dividend Payout % | 23% | 21% | 23% | 36% | 22% | 16% | 13% | 20% | 18% | 18% | 46% | 21% |
Compounded Sales Growth | |
---|---|
10 Years: | 7% |
5 Years: | 7% |
3 Years: | -6% |
TTM: | 18% |
Compounded Profit Growth | |
---|---|
10 Years: | 8% |
5 Years: | -2% |
3 Years: | -20% |
TTM: | 633% |
Stock Price CAGR | |
---|---|
10 Years: | 13% |
5 Years: | 15% |
3 Years: | -6% |
1 Year: | 1% |
Return on Equity | |
---|---|
10 Years: | 12% |
5 Years: | 9% |
3 Years: | 6% |
Last Year: | 7% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
Reserves | 145 | 178 | 201 | 352 | 434 | 584 | 595 | 710 | 926 | 985 | 1,069 | 1,171 |
102 | 95 | 89 | 68 | 10 | 7 | 24 | 9 | 7 | 3 | 2 | 12 | |
97 | 106 | 121 | 132 | 167 | 181 | 197 | 229 | 292 | 230 | 334 | 272 | |
Total Liabilities | 349 | 384 | 418 | 559 | 618 | 779 | 823 | 953 | 1,232 | 1,225 | 1,412 | 1,461 |
128 | 157 | 164 | 180 | 199 | 235 | 376 | 389 | 427 | 428 | 424 | 459 | |
CWIP | 20 | 3 | 3 | 8 | 23 | 12 | 10 | 17 | 21 | 19 | 19 | 8 |
Investments | 14 | 14 | 14 | 152 | 175 | 261 | 156 | 209 | 295 | 359 | 583 | 635 |
187 | 210 | 237 | 218 | 220 | 272 | 281 | 339 | 489 | 419 | 386 | 359 | |
Total Assets | 349 | 384 | 418 | 559 | 618 | 779 | 823 | 953 | 1,232 | 1,225 | 1,412 | 1,461 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
13 | 44 | 46 | 35 | 120 | 135 | 110 | 90 | 109 | 127 | 73 | 63 | |
-32 | -27 | -27 | 12 | -48 | -109 | -65 | -48 | -106 | -117 | -52 | -46 | |
20 | -23 | -17 | -48 | -73 | -24 | -31 | -17 | -17 | -35 | -17 | -16 | |
Net Cash Flow | 1 | -5 | 1 | -1 | -2 | 2 | 14 | 25 | -14 | -25 | 4 | 2 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 89 | 80 | 107 | 95 | 75 | 68 | 78 | 84 | 62 | 52 | 82 | 81 |
Inventory Days | 74 | 103 | 102 | 84 | 76 | 72 | 90 | 71 | 103 | 78 | 80 | 68 |
Days Payable | 81 | 84 | 115 | 98 | 123 | 106 | 122 | 126 | 112 | 64 | 139 | 99 |
Cash Conversion Cycle | 82 | 99 | 93 | 81 | 27 | 33 | 46 | 29 | 52 | 67 | 23 | 50 |
Working Capital Days | 76 | 73 | 86 | 88 | 58 | 60 | 60 | 53 | 62 | 60 | 57 | 137 |
ROCE % | 14% | 24% | 17% | 11% | 26% | 45% | 19% | 15% | 26% | 11% | 2% | 10% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
3h - Newspaper advertisement published for giving notice to shareholders on transfer of Equity Shares of the Company to the Investor Education and Protection Fund.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
16 May - Audio recording of Q4 and FY 2024-25 earnings call uploaded on company website.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
15 May - Listing Obligation and Disclosure Requirements) Regulations,2015, request you to take on record Investor Presentation on the audited financial results for the quarter and year ended …
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 May - Company''s Audited Financial Results for the quarter ended 31st March, 2025 have been published in newspaper.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
15 May - Annual Secretarial Compliance Report for FY ended 31 Mar 2025 filed by Excel Industries.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
May 2025TranscriptNotesPPT
-
Feb 2025TranscriptNotesPPT
-
Nov 2024TranscriptNotesPPT
-
Aug 2024TranscriptNotesPPT
-
May 2024TranscriptNotesPPT
-
Feb 2024TranscriptNotesPPT
-
Nov 2023TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
May 2023TranscriptNotesPPT
-
Feb 2023TranscriptNotesPPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
Market Position
The company is the No. 1 Producer of DETC (Diethylthiophosphoryl Chloride) and one of the Top 5 Producers of Phosphonates in the world. [1]